Markets Try to Shake Off April Blues [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
S&P 500 and Nasdaq; the blue-chip Dow outperformed the field yesterday, closing +0.17%. Major indices are all lower over the past month, from -1.7% (tech-heavy Nasdaq) to -2.9% (small-cap Russell 2000). Year to date, only the Russell is back in the red — the Dow is +0.3%, the S&P is +6.7% and the Nasdaq is +7.2%. Late March highs — including all-time S&P levels — have given way to profit-taking and existential concerns. Q1 earnings season rolls along. Abbott Laboratories ABT outperformed expectations on both top and bottom lines in its Q1 report ahead of today's opening bell. Earnings of 98 cents per share (excluding specific items) surpassed the Zacks consensus by 2 cents (though down from the $1.03 per share reported a year ago), while quarterly sales came in at $10.0 billion even, nicely ahead of the $9.85 billion projected. Full-year earnings guidance narrowed in-line with previous consensus. The Big Pharma company only has one earnings miss in the past five years, and brought a
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Global Drug-Eluting Stents Strategic Research Report 2024-2030: Biodegradable Polymers Represent Promising Developments, Offering the Potential for Enhanced Biocompatibility [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee [Yahoo! Finance]Yahoo! Finance
- Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneePR Newswire
- ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside? [Yahoo! Finance]Yahoo! Finance
- Global Penicillin Analysis Report 2024: Market to Grow by $2.82 Billion During 2023-2028, Driven by M&As, and Special Regulatory Designations Driving the Quality of Penicillin [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/29/24 - Form 8-K
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- ABT's page on the SEC website